REDWOOD CITY, Calif., March 23 /PRNewswire-FirstCall/ -- Genomic Health, Inc. today announced that Randy Scott, Ph.D., Genomic Health's Chairman and Chief Executive Officer, will present at Thomson Financial and BioCentury's Future Leaders in the Biotech Industry Conference in New York on Thursday, March 30, 2006 at 2:00 p.m. Eastern Time.
To access the live and subsequently archived webcast of the presentation, visit the Investor Relations section of Genomic Health's website at http://investor.genomichealth.com . Please connect to the web site at least 15 minutes prior to the beginning of the presentation to allow for any necessary software downloads. An archived replay will be available for three months beginning 24 hours after the live presentation.
About Genomic Health
Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched its first test, Oncotype DX(TM), which has been shown to predict the likelihood of breast cancer recurrence and chemotherapy benefit in early stage breast cancer patients. The company was founded in 2000 and is located in Redwood City, California. For more information, please visit www.genomichealth.com.
Genomic Health, Inc.CONTACT: Brad Cole of Genomic Health, Inc., +1-650-569-2281, orinvestors@genomichealth.com; or media, Emily Faucette of WeissCommPartners, +1-415-946-1066, or media@genomichealth.com, for Genomic Health,Inc.
Web site: http://www.genomichealth.com/
